Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
-$7M |
 |
AmarinAMRN |
$1.7M |
 |
Gilead SciencesGILD |
-$127M |
 |
Anavex Life SciencesAVXL |
-$14M |
 |
Inovio PharmaceuticalsINO |
-$2.2M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Betz Stephen F. | Sep 10, 2024 | Sell | 1,035 | $51.5 | $53,000 |
| Betz Stephen F. | Aug 26, 2024 | Sell | 3,000 | $53.19 | $160,000 |
| Betz Stephen F. | Aug 12, 2024 | Sell | 3,000 | $47.68 | $140,000 |
| Wilson Marc | Jul 25, 2024 | Sell | 19,056 | $53.88 | $1M |
| Betz Stephen F. | Jul 25, 2024 | Sell | 3,000 | $53.43 | $160,000 |
| Knight Jeff E. | Jul 15, 2024 | Sell | 27,000 | $55 | $1.5M |
| Wilson Marc | Jul 15, 2024 | Sell | 25,000 | $55 | $1.4M |
| Betz Stephen F. | Jul 10, 2024 | Sell | 3,000 | $48.55 | $150,000 |
| Hassard James | Jul 5, 2024 | Sell | 15,000 | $44.08 | $660,000 |
| Pizzuti Dana | Jul 3, 2024 | Sell | 14,375 | $44.87 | $650,000 |
| Wilson Marc | Jun 28, 2024 | Sell | 32,129 | $43.61 | $1.4M |
| Knight Jeff E. | Jun 26, 2024 | Sell | 956 | $44.38 | $42,000 |
| Betz Stephen F. | Jun 25, 2024 | Sell | 3,000 | $45.37 | $140,000 |
| Pizzuti Dana | Jun 24, 2024 | Sell | 9,500 | $45.73 | $430,000 |
| Hassard James | Jun 21, 2024 | Sell | 15,000 | $44.66 | $670,000 |
| Betz Stephen F. | Jun 10, 2024 | Sell | 3,000 | $43.86 | $130,000 |
| Betz Stephen F. | May 28, 2024 | Sell | 3,000 | $47.49 | $140,000 |
| Betz Stephen F. | May 10, 2024 | Sell | 3,000 | $49.43 | $150,000 |
| Struthers Richard Scott | May 8, 2024 | Sell | 107,448 | $49.4 | $5.3M |
| Pizzuti Dana | Apr 15, 2024 | Sell | 14,375 | $44.47 | $640,000 |
| Struthers Richard Scott | Apr 4, 2024 | Sell | 40,951 | $49.17 | $2M |
| Okey Stephanie | Mar 28, 2024 | Sell | 17,500 | $46.38 | $810,000 |
| Knight Jeff E. | Mar 22, 2024 | Sell | 30,000 | $44.22 | $1.3M |
| Knight Jeff E. | Mar 22, 2024 | Sell | 2,359 | $45.39 | $110,000 |
| Pizzuti Dana | Mar 20, 2024 | Sell | 10,000 | $43.28 | $430,000 |
| Fust Matthew K | Mar 20, 2024 | Sell | 17,500 | $45.5 | $800,000 |
| Fust Matthew K | Mar 20, 2024 | Sell | 12,500 | $43.57 | $540,000 |
| Pizzuti Dana | Mar 20, 2024 | Sell | 4,375 | $45.89 | $200,000 |
| Pizzuti Dana | Mar 20, 2024 | Sell | 714 | $43.69 | $31,000 |
| Wilson Marc | Mar 19, 2024 | Sell | 6,942 | $42.91 | $300,000 |
| Betz Stephen F. | Jan 25, 2024 | Sell | 3,000 | $37.26 | $110,000 |
| Betz Stephen F. | Jan 10, 2024 | Sell | 3,000 | $37.65 | $110,000 |
| Pizzuti Dana | Jan 3, 2024 | Sell | 14,375 | $35 | $500,000 |
| Wilson Marc | Jan 2, 2024 | Sell | 10,000 | $35.47 | $350,000 |
| Betz Stephen F. | Dec 26, 2023 | Sell | 3,000 | $35.89 | $110,000 |
| Pizzuti Dana | Dec 21, 2023 | Sell | 9,583 | $34.57 | $330,000 |
| Betz Stephen F. | Dec 11, 2023 | Sell | 3,000 | $32.87 | $99,000 |
| Betz Stephen F. | Nov 27, 2023 | Sell | 3,000 | $31.84 | $96,000 |
| Struthers Richard Scott | Nov 3, 2023 | Sell | 199,082 | $30.56 | $6.1M |
| Struthers Richard Scott | Nov 2, 2023 | Sell | 918 | $29.95 | $27,000 |
| Wilson Marc | Nov 1, 2023 | Sell | 10,000 | $28.75 | $290,000 |
| Krasner Alan Seth | Oct 17, 2023 | Sell | 7,000 | $30 | $210,000 |
| Struthers Richard Scott | Jul 13, 2023 | Sell | 14,157 | $20.35 | $290,000 |
| Struthers Richard Scott | Jul 12, 2023 | Sell | 11,459 | $20.17 | $230,000 |
| Struthers Richard Scott | Jul 11, 2023 | Sell | 24,384 | $20.14 | $490,000 |
| Wilson Marc | Jun 20, 2023 | Sell | 20,000 | $19.97 | $400,000 |
| Wilson Marc | Jun 20, 2023 | Sell | 10,922 | $19.96 | $220,000 |
| Struthers Richard Scott | Jun 16, 2023 | Sell | 50,000 | $20.81 | $1M |
| Vivaldi Coelho Rogerio | Jun 8, 2023 | Buy | 5,000 | $22.06 | $110,000 |
| Pizzuti Dana | Apr 5, 2023 | Sell | 8,212 | $16.15 | $130,000 |
| Betz Stephen F. | Feb 1, 2023 | Sell | 3,126 | $19.59 | $61,000 |
| Betz Stephen F. | Jan 25, 2023 | Sell | 8,336 | $21.07 | $180,000 |
| Betz Stephen F. | Jan 17, 2023 | Sell | 3,126 | $18 | $56,000 |
| Betz Stephen F. | Jan 3, 2023 | Sell | 3,126 | $18.35 | $57,000 |
| Betz Stephen F. | Dec 15, 2022 | Sell | 3,126 | $16 | $50,000 |
| Betz Stephen F. | Dec 1, 2022 | Sell | 3,126 | $17.84 | $56,000 |
| Betz Stephen F. | Nov 15, 2022 | Sell | 3,126 | $18.72 | $59,000 |
| Betz Stephen F. | Nov 1, 2022 | Sell | 3,126 | $18.52 | $58,000 |
| Betz Stephen F. | Oct 17, 2022 | Sell | 3,126 | $17.73 | $55,000 |
| Betz Stephen F. | Oct 3, 2022 | Sell | 3,126 | $19.64 | $61,000 |
What's the latest insider transaction for Crinetics Pharmaceuticals?
The most recent insider transaction for Crinetics Pharmaceuticals was conducted by Betz Stephen F., who sold 1,035 shares on September 10, 2024 at a price of $51.50 per share.
Which insider bought the most CRNX stock over the last two years?
Vivaldi Coelho Rogerio has bought the most CRNX stock in the last 2 years, with a total value of $110,000.
Which insider has sold the most CRNX stock over the last two years?
Struthers Richard Scott has sold the most CRNX stock in the last 2 years, with a total value of $15M.
What is the total value of insider transactions for Crinetics Pharmaceuticals (CRNX) in the last 2 years?
The total value of insider transactions for Crinetics Pharmaceuticals in the last 2 years is negative, amounting to -$33M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Crinetics Pharmaceuticals' market confidence?
Over the last 2 years, insider transactions for Crinetics Pharmaceuticals have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.